TrademarkOpen
Search / United States / 97800094

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

PLEXAFORM

Allowed — statement of use stage
Third Extension - Granted
Used for: Pharmaceuticals for the treatment of spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain…
Show more

Class 5: Pharmaceuticals for the treatment of spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain
Class 42: Providing information in the field of medical research; research and development of pharmaceuticals; providing information in the field of medical research related to pharmaceuticals; Educational services, namely, instruction in methods of treating spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 21 Feb 2023
    Application filed
    New Application Entered
  2. 16 Nov 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 20 Nov 2023
    Office action issued
    Non-Final Action Written
  4. 17 May 2024
    Response to office action filed
    Teas Response To Office Action Received
  5. 23 May 2024
    Final refusal issued
    Final Refusal Mailed
  6. 4 Dec 2024
    Approved for publication
    Approved For Pub - Principal Register
  7. 31 Dec 2024
    Published for opposition
    Published For Opposition
  8. 25 Feb 2025
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  9. 14 Aug 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  10. 3 Feb 2026
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  11. 30 Jul 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 36 events
2026-07-31Notice Of Approval Of Extension Request E-Mailed
2026-07-30Sou Teas Extension Received
2026-07-30Sou Extension 3 Filed
2026-07-30Sou Extension 3 Granted
2026-02-04Notice Of Approval Of Extension Request E-Mailed
2026-02-03Sou Teas Extension Received
2026-02-03Sou Extension 2 Filed
2026-02-03Sou Extension 2 Granted
2025-08-15Notice Of Approval Of Extension Request E-Mailed
2025-08-14Sou Teas Extension Received
2025-08-14Sou Extension 1 Filed
2025-08-14Sou Extension 1 Granted
2025-02-25Noa Mailed - Sou Required From Applicant
2024-12-31Published For Opposition
2024-12-31Official Gazette Publication Confirmation E-Mailed
2024-12-25Notification Of Notice Of Publication E-Mailed
2024-12-04Approved For Pub - Principal Register
2024-11-22Teas Request For Reconsideration Received
2024-11-22Correspondence Received In Law Office
2024-11-22Teas/Email Correspondence Entered
2024-06-21Application Extension To Response Period - Received
2024-06-21Application Extension Granted/Receipt Provided
2024-05-23Final Refusal Mailed
2024-05-23Final Refusal E-Mailed
2024-05-23Notification Of Final Refusal Emailed
2024-05-17Teas Response To Office Action Received
2024-05-17Correspondence Received In Law Office
2024-05-17Teas/Email Correspondence Entered
2024-02-16Application Extension To Response Period - Received
2024-02-16Application Extension Granted/Receipt Provided
2023-11-20Non-Final Action Written
2023-11-20Non-Final Action E-Mailed
2023-11-20Notification Of Non-Final Action E-Mailed
2023-11-16Assigned To Examiner
2023-03-08New Application Office Supplied Data Entered
2023-02-21New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceuticals for the treatment of spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain

Class 42 Technology & SaaS

Providing information in the field of medical research; research and development of pharmaceuticals; providing information in the field of medical research related to pharmaceuticals; Educational services, namely, instruction in methods of treating spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 31 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.